Worldwide Coagulation Testing Industry Segments Growth: Point-of-Care Coagulation Testing and Home Diagnostics

Coagulation tests help in measuring the clotting ability of blood. Clotting is the process of blood converting from liquid into gel form. Coagulation tests are performed to analyze clotting disorders such as hemorrhage and thrombosis. Coagulation tests include complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving patients’ quality of life.

Analysts forecast the Global Coagulation Testing market to grow at a CAGR of 5.62 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global Coagulation Testing Market: Abbott Laboratories, Danaher Corp., Roche Diagnostics and Sysmex Corp.

Other Prominent Vendors in the market are: Alere, Cepheid, CoaguSense, Helena Laboratories, HYPEN BioMed, LABiTec, Medtronic, Siemens, Sienco and Stago.

An expansion of some of the economies in the APAC region is one of the main trends seen in this market. Governments in emerging countries are making efforts to improve healthcare infrastructure, which has benefited the Coagulation Testing market.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=25851 .

Covered in this Report

The Global Coagulation Testing market can be segmented into the revenue generated from end- user application such as: Point-of-Care Coagulation Testing and Home Diagnostics.

Global Coagulation Testing market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Coagulation Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers in the market is the increase in the prevalence of cardiovascular disease. CVD deaths occur almost equally in men and women and it is predicted that by 2030 almost 23.6 million people will die from CVD. An increase in the prevalence of CVD has led to the development of coagulation testing products, and thus, the growth of the market.

Further, the report states that one of the major challenges in the market is the high cost incurred in R&D activities. Many big vendors are facing the frequent elimination of coagulation testing analyzer products because of rapid developments with respect to the technological aspects of coagulation testing analyzers.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25851 .

New Report – Global Drug Abuse Testing Market 2014-2018

Drugs are chemical substances, which are generally used in the diagnosis, treatment, and prevention of diseases. Drugs when used as medicines have positive effects on patients; however, some people use drugs for non-medical purposes, which leads to serious health problems. Drug abuse testing is a technical analysis of biological specimen to determine the drugs or combination of drugs consumed by a person. The biological specimens used for the test are saliva, urine, blood, hair, breath, and sweat. The two main technologies used to test drug abuse are immunoassay and chromatography. Drug abuse testing is widely used in diagnostics, criminal cases, and to screen sports athletes.

Analysts forecast the Global Drug Abuse Testing market to grow at a CAGR of 4.71 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global Drug Abuse Testing Market: Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Other Prominent Vendors in the market are: Abbott Laboratories, Agilent Technologies, Alere , Biomedical Diagnostics, Branan Medical, OraSure Technologies, PerkinElmer, Psychemedics, Quest Diagnostic, Randox Laboratories, Sigma-Aldrich, Sonic Healthcare and Waters.

One of the major trends upcoming in the market is the increase in the number of collaborations and M&A in the market. This strategy helps vendors to expand their portfolio as well as improve the quality and performance of their products.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=25855 .

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Drug Abuse Testing market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography.

Global Drug Abuse Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Drug Abuse Testing market landscape and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

According to the report, the rising consumption of illicit drugs is a major driver in the Global Drug Abuse Testing market as the use of illicit drugs in developed as well as in developing countries is increasing worldwide.

Further, the report states that one of the key challenges that the market faces is the inability of drug abuse testing products to detect low-dose designer drugs. The detection of designer drugs such as ecstasy, Rohypnol, and LSD is very difficult.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25855 .

Worldwide Multiplexed Diagnostics Industry Trends Challenges and Key Vendors Analysis Report 2018

Multiplexed diagnostics refer to equipment that are used for analyzing multiple analytes in the single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing.

Analysts forecast the Global Multiplexed Diagnostics market to grow at a CAGR of 20.05 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global Multiplexed Diagnostics Market: Affymetrix Inc., Agilent Technologies, bioMérieux SA, F. Hoffmann-La Roche, Illumina Inc. and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, Hologic, Luminex, Qiagen and Siemens Healthcare.

Expanding economies in the Asia Pacific region is a major trend in the market. The governments in emerging countries are making efforts to improve the healthcare infrastructure, which has benefited the Global Multiplexed Diagnostics market.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=25194 .

Covered in this Report

The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing.

Global Multiplexed Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers in the market is an increase in technological innovations to provide efficient and inexpensive devices to diagnose and treat diseases. Advances in technology and innovations in the Healthcare industry have resulted in the development of equipment customized to the needs of patients.

Further, the report states that accurate diagnostic testing and the rate of false positive and false negative results are the major issues in the market. The rate of false positive and false negative results, which mostly occur during the window period, is a major challenge to the Global Multiplexed Diagnostics market.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25194 .

Global IVD Industry Report for Growth and Revenue Forecast 2018

View a Presentation on Global IVD Market 2014-2018

 IVDs are widely used to diagnose, monitor, and assess medical conditions, diseases, or infections usually in a controlled environment. IVD tests provide outcomes for earlier and more targeted treatment. These tests are minimally invasive, help reduce hospital stay, and provide accurate results. This kind of diagnostics provides early detection of diseases and thereby helps better control and curb the burden of diseases across the world.

Analysts forecast the Global IVD market will grow at a CAGR of 6.86 percent over the period 2013-2018.

The Repoer recognizes the following companies as the key players in Global IVD Market: Abbott Laboratories, Johnson & Johnson, Roche Diagnostics Inc., Siemens Healthcare, 23andMe, A. Menarini Diagnostics, Affymetrix, Agilent Technologies, Alere, ARKRAY, Axis-Shield , Bio-Rad Laboratories, Bruker BioSciences, Celera Diagnostics , Cepheid, China Medical Technologies, Dako , DiaSorin , Eiken Chemical , ELITech , Fujirebio Diagnostics, GE Healthcare, Grifols , Horiba, Illumina, Instrumentation Laboratory, IRIS International, Luminex, Magellan Biosciences, Nanosphere, Nova Biomedical, Nova Century Scientific, Novartis , PerkinElmer, Phadia , QIAGEN , Quidel, Randox Laboratories, Sequenom, Shenzhen Mindray  Bio-Medical Electronics , Siemens Healthcare, Spartan Bioscience , Sysmex, Thermo Fisher Scientific , Tosoh , Transasia Bio-Medicals , Trinity Biotech , Ventana Medical Systems , Veridex , Wako Pure Chemical Industries , Werfen Life Group

In the recent past, there has been an increased adoption of POC diagnostic tests by patients. This is because these tests provide rapid results and help influence treatment decisions immediately. This, in turn, reduces the length of patient stays in hospitals and backlogs in areas such as emergency departments where patients have to wait for test results. Currently, POC tests are available for blood glucose testing, pregnancy testing, hemoglobin testing, rapid coagulation testing, cardiac markers diagnostics, blood gas, electrolytes analysis, urine testing, fecal occult blood analysis, food pathogens screening, infectious disease testing, and cholesterol screening. Among these, pregnancy tests and blood glucose testing are the most commonly used POC diagnostic tests. Hence, the increased adoption of POC diagnostic tests is expected to increase the growth of the market during the forecast period.

Covered in this Report

The Global IVD market can be categorized on the basis of type of test into the following segments: POC, Core Laboratory, Molecular, Hematology, Coagulation, Microbiology, Blood Banking, and Histology/Cytology.

Global IVD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global IVD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers in this market is the rapid increase in the aging population across the world. The aging population is at a greater risk of acquiring chronic diseases and infections, which has fostered the demand for rapid MI and non-invasive IVD testing. This, in turn, has increased the volume of diagnostic laboratory tests being performed across the world.

Further, the report states that one of the major challenges is the issues in the regulatory framework for IVD products. Improper and stringent regulations by the FDA and regulatory authorities in the EU for certain IVD tests are hindering the adoption of these tests.

2018 Global High-performance Liquid Chromatography (HPLC) Systems and Accessories Market

Industry Review: Global High-performance Liquid Chromatography (HPLC) Systems and Accessories Market 2014-2018

Analysts forecast the Global High-performance Liquid Chromatography (HPLC) Systems and Accessories market will grow at a CAGR of 5.52 percent over the period 2013-2018. The Report recognizes the following companies as the key players in Global High-performance Liquid Chromatography (HPLC) Systems and Accessories Market: Agilent Technologies Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., Waters Corp., Bio-Rad Laboratories Inc., Gilson Inc., Hitachi High Technologies America Inc., Jasco Inc., Perkin Elmer Inc., Sigma Aldrich Corp., ZirChrom Separations Inc.

This report covers the present scenario and the growth prospects of the Global HPLC Systems and Accessories market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of:

• HPLC Chromatography Systems
• Accessories

It also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the Global HPLC Systems and Accessories market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

One of the major trends witnessed in the market is the increased outsourcing of drug manufacturing to the APAC region. Many global pharmaceutical companies are facing several challenges such as patent expirations and pricing pressure. As a result, these companies are on the lookout for cost-containment measures. For instance, drug manufacture in the APAC countries is less expensive than in the Western countries. Therefore, Western nations are increasingly outsourcing all the stages of the drug manufacturing process, including the purification of biopharmaceutical and other biochemical entities, to CROs and CMOs located in the APAC region to achieve cost-efficiency. As a result, the APAC region is emerging as the fastest growing market, and many multinational companies and local companies have set up their operations in this region to provide automated HPLC systems to CROs and CMOs. Hence, the continuous outsourcing of pharmaceutical production to the APAC region is expected to drive the growth of Global HPLC Systems and Accessories market.

According to the report, one of the major drivers in this market is the increasing automation of HPLC systems. The usage of automated instruments with auto-samplers to process a large numbers of samples and the usage of analyzers with customized system settings have been gaining popularity in recent times. Many companies have adopted HPLC systems to meet the demands of the Life Sciences industry.

Further, the report states that one of the major challenges in this market is a requirement for high purification standards. To maintain the efficiency of the HPLC instruments, the vendors are forced to build standards to deliver the highest quality systems. Moreover, the complex nature of biochemical entities poses a challenge for the vendors to develop and maintain the instrument standards for purification.

The Global HPLC Systems and Accessories Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HPLC Systems and Accessories market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Read the Complete Report with TOC

Global In-vitro Toxicity Testing Market Reviewed 2018

The Global In Vitro Toxicity Testing market can be divided into four end-user segments: Cosmetics and Personal Care Industry, Pharmaceuticals Industry, Food Industry, and Chemicals Industry. The Global In Vitro Toxicity Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global In Vitro Toxicity Testing market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report also includes a discussion of the key vendors operating in this market.

Analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. Animal welfare organizations across the world are supporting in vitro toxicity testing. Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as cruelty-free food, cosmetics, and clothing as cruelty-free testing does not damage the environment or produce harmful waste. For instance, the Body Shop follows a no-animal-tests policy to sell its products. Thus, the increase in animal-free testing campaigns has opened up new avenues for the market.

The report recognizes the following companies as the key players in Global In-vitro Toxicity Testing Market: Accelrys Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc. , Covance Inc. , Entelos Inc., MattekCorp., Molecular Toxicology Inc., RTI Health Solutions, SBW Ltd., Smithers Group Inc., Xenobiotic Detection SystemsInc., Xenometrix AG.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

According to the report, the Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market.

Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques.

View Complete Report with Table of Content